DE202009013228U1 - Gluten-free foods - Google Patents
Gluten-free foods Download PDFInfo
- Publication number
- DE202009013228U1 DE202009013228U1 DE202009013228U DE202009013228U DE202009013228U1 DE 202009013228 U1 DE202009013228 U1 DE 202009013228U1 DE 202009013228 U DE202009013228 U DE 202009013228U DE 202009013228 U DE202009013228 U DE 202009013228U DE 202009013228 U1 DE202009013228 U1 DE 202009013228U1
- Authority
- DE
- Germany
- Prior art keywords
- flour
- composition according
- gluten
- seeds
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 67
- 235000013312 flour Nutrition 0.000 claims abstract description 56
- 241000196324 Embryophyta Species 0.000 claims abstract description 20
- 239000000835 fiber Substances 0.000 claims abstract description 19
- 239000004615 ingredient Substances 0.000 claims abstract description 18
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 18
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract description 17
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 13
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 13
- 235000018102 proteins Nutrition 0.000 claims abstract description 13
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 13
- 239000006014 omega-3 oil Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 235000019197 fats Nutrition 0.000 claims abstract description 9
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 7
- 235000003421 Plantago ovata Nutrition 0.000 claims abstract description 6
- 239000009223 Psyllium Substances 0.000 claims abstract description 6
- 229940070687 psyllium Drugs 0.000 claims abstract description 6
- 235000015097 nutrients Nutrition 0.000 claims abstract description 4
- 235000013339 cereals Nutrition 0.000 claims description 25
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 20
- 235000008429 bread Nutrition 0.000 claims description 16
- 235000015927 pasta Nutrition 0.000 claims description 16
- 201000010099 disease Diseases 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 10
- 240000006240 Linum usitatissimum Species 0.000 claims description 10
- 208000015943 Coeliac disease Diseases 0.000 claims description 9
- 235000010469 Glycine max Nutrition 0.000 claims description 9
- 235000004426 flaxseed Nutrition 0.000 claims description 9
- 235000012907 honey Nutrition 0.000 claims description 8
- 244000025254 Cannabis sativa Species 0.000 claims description 7
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 7
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 7
- 241000408747 Lepomis gibbosus Species 0.000 claims description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 235000009120 camo Nutrition 0.000 claims description 7
- 235000005607 chanvre indien Nutrition 0.000 claims description 7
- 239000011487 hemp Substances 0.000 claims description 7
- 235000013372 meat Nutrition 0.000 claims description 7
- 235000020236 pumpkin seed Nutrition 0.000 claims description 7
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 6
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 244000134552 Plantago ovata Species 0.000 claims description 5
- 244000294611 Punica granatum Species 0.000 claims description 5
- 235000014360 Punica granatum Nutrition 0.000 claims description 5
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 5
- 244000062793 Sorghum vulgare Species 0.000 claims description 5
- 229940087559 grape seed Drugs 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 208000024827 Alzheimer disease Diseases 0.000 claims description 4
- 244000075850 Avena orientalis Species 0.000 claims description 4
- 235000007319 Avena orientalis Nutrition 0.000 claims description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 4
- 235000009973 maize Nutrition 0.000 claims description 4
- 230000004770 neurodegeneration Effects 0.000 claims description 4
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 4
- 229940033080 omega-6 fatty acid Drugs 0.000 claims description 4
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims description 4
- 235000017807 phytochemicals Nutrition 0.000 claims description 4
- 229930000223 plant secondary metabolite Natural products 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims description 3
- 240000001592 Amaranthus caudatus Species 0.000 claims description 3
- 240000006162 Chenopodium quinoa Species 0.000 claims description 3
- 235000014966 Eragrostis abyssinica Nutrition 0.000 claims description 3
- 235000010451 Plantago psyllium Nutrition 0.000 claims description 3
- 244000090599 Plantago psyllium Species 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 235000012735 amaranth Nutrition 0.000 claims description 3
- 239000004178 amaranth Substances 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 230000003449 preventive effect Effects 0.000 claims description 3
- 239000008347 soybean phospholipid Substances 0.000 claims description 3
- 206010006895 Cachexia Diseases 0.000 claims description 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 2
- 208000011231 Crohn disease Diseases 0.000 claims description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000012970 cakes Nutrition 0.000 claims description 2
- 235000021466 carotenoid Nutrition 0.000 claims description 2
- 150000001747 carotenoids Chemical class 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 229930003935 flavonoid Natural products 0.000 claims description 2
- 235000017173 flavonoids Nutrition 0.000 claims description 2
- 150000002215 flavonoids Chemical class 0.000 claims description 2
- 125000004383 glucosinolate group Chemical group 0.000 claims description 2
- 208000028774 intestinal disease Diseases 0.000 claims description 2
- 201000000083 maturity-onset diabetes of the young type 1 Diseases 0.000 claims description 2
- 235000019713 millet Nutrition 0.000 claims description 2
- 235000012149 noodles Nutrition 0.000 claims description 2
- 229940068065 phytosterols Drugs 0.000 claims description 2
- 235000013550 pizza Nutrition 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
- 235000020238 sunflower seed Nutrition 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 244000000231 Sesamum indicum Species 0.000 claims 2
- 241000746966 Zizania Species 0.000 claims 1
- 235000002636 Zizania aquatica Nutrition 0.000 claims 1
- 229930003658 monoterpene Natural products 0.000 claims 1
- 150000002773 monoterpene derivatives Chemical class 0.000 claims 1
- 235000002577 monoterpenes Nutrition 0.000 claims 1
- 239000003075 phytoestrogen Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 235000017709 saponins Nutrition 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
- 241001499733 Plantago asiatica Species 0.000 abstract 1
- 108010068370 Glutens Proteins 0.000 description 18
- 235000021312 gluten Nutrition 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 241000219051 Fagopyrum Species 0.000 description 14
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 235000014571 nuts Nutrition 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 101000800498 Homo sapiens Transketolase-like protein 1 Proteins 0.000 description 6
- 102100033108 Transketolase-like protein 1 Human genes 0.000 description 6
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 3
- 235000007238 Secale cereale Nutrition 0.000 description 3
- 244000040738 Sesamum orientale Species 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- -1 for example Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000019895 oat fiber Nutrition 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 235000011888 snacks Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- UBJVUCKUDDKUJF-UHFFFAOYSA-N Diallyl sulfide Chemical compound C=CCSCC=C UBJVUCKUDDKUJF-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000004153 glucose metabolism Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 1
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- VZRRCQOUNSHSGB-UHFFFAOYSA-N 4-hydroxy-4,6,6-trimethylbicyclo[3.1.1]heptan-3-one Chemical compound C1C2C(C)(C)C1CC(=O)C2(O)C VZRRCQOUNSHSGB-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 244000249359 Avena odorata Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 244000191482 Cantharellus cibarius Species 0.000 description 1
- 235000015722 Cantharellus cibarius Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IVYPNXXAYMYVSP-UHFFFAOYSA-N Indole-3-carbinol Natural products C1=CC=C2C(CO)=CNC2=C1 IVYPNXXAYMYVSP-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000002769 Morchella esculenta Species 0.000 description 1
- 235000002779 Morchella esculenta Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 102000014701 Transketolase Human genes 0.000 description 1
- 108010043652 Transketolase Proteins 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 108010050181 aleurone Proteins 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- 150000004783 arabinoxylans Chemical class 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- BTNNPSLJPBRMLZ-LGMDPLHJSA-N benfotiamine Chemical compound C=1C=CC=CC=1C(=O)SC(/CCOP(O)(O)=O)=C(/C)N(C=O)CC1=CN=C(C)N=C1N BTNNPSLJPBRMLZ-LGMDPLHJSA-N 0.000 description 1
- 229960002873 benfotiamine Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000020113 brazil nut Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 206010016165 failure to thrive Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 235000011617 hard cheese Nutrition 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000021408 high quality diet Nutrition 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 235000002279 indole-3-carbinol Nutrition 0.000 description 1
- RUMVKBSXRDGBGO-UHFFFAOYSA-N indole-3-carbinol Chemical compound C1=CC=C[C]2C(CO)=CN=C21 RUMVKBSXRDGBGO-UHFFFAOYSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000002361 ketogenic effect Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000006676 mitochondrial damage Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 239000003895 organic fertilizer Substances 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000006950 reactive oxygen species formation Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/264—Vegetable proteins
- A21D2/265—Vegetable proteins from cereals, flour, bran
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/04—Products made from materials other than rye or wheat flour
- A21D13/047—Products made from materials other than rye or wheat flour from cereals other than rye or wheat, e.g. rice
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/02—Products made from whole meal; Products containing bran or rough-ground grain
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/04—Products made from materials other than rye or wheat flour
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/04—Products made from materials other than rye or wheat flour
- A21D13/045—Products made from materials other than rye or wheat flour from leguminous plants
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
- A21D13/062—Products with modified nutritive value, e.g. with modified starch content with modified sugar content; Sugar-free products
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
- A21D13/064—Products with modified nutritive value, e.g. with modified starch content with modified protein content
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
- A21D13/064—Products with modified nutritive value, e.g. with modified starch content with modified protein content
- A21D13/066—Gluten-free products
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
- A21D13/068—Products with modified nutritive value, e.g. with modified starch content with modified fat content; Fat-free products
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/40—Products characterised by the type, form or use
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/40—Products characterised by the type, form or use
- A21D13/41—Pizzas
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/264—Vegetable proteins
- A21D2/266—Vegetable proteins from leguminous or other vegetable seeds; from press-cake or oil bearing seeds
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/362—Leguminous plants
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/364—Nuts, e.g. cocoa
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/109—Types of pasta, e.g. macaroni or noodles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pediatric Medicine (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Agronomy & Crop Science (AREA)
Abstract
Zusammensetzung für ein glutenfreies und Omega-3-Fettsäuren enthaltendes Nahrungsmittel, dadurch gekennzeichnet, dass sie folgende Inhaltsstoffe aufweist:
– Mehl und/oder Kleie aus zumindest einer glutenfreien Pflanze,
– einem auf Soja, Hafer und/oder Flohsamen basierendem Ballaststoffpulver, vorzugsweise SolaGrainTM,
– Ölsaaten und/oder Kerne und/oder Nüsse in zerkleinerter Form,
– Presskuchen von Ölsaaten und/oder Kernen und/oder Nüssen,
und dass sie folgendes Nährstoffprofil aufweist:
- flour and / or bran from at least one gluten-free plant,
A fiber powder based on soy, oat and / or psyllium, preferably SolaGrain ™ ,
- oilseeds and / or kernels and / or nuts in crushed form,
- press cake of oilseeds and / or kernels and / or nuts,
and that it has the following nutrient profile:
Description
Die vorliegende Erfindung betrifft eine Zusammensetzung für ein glutenfreies Nahrungsmittel, sowie Back- und Teigwaren, die ausgehend von der erfindungsgemäßen Zusammensetzung gewonnen werden können.The present invention relates to a composition for a gluten-free food, as well as bakery and pasta, which can be obtained from the composition of the invention.
Gluten ist ein Klebereiweiß, das in Weizen, Roggen-, Gerste-, Hafer- und Dinkelmehl sowie in den damit verwandten Getreidesorten enthalten ist. Es stellt ein Gemisch aus Proteinen, Lipiden und Kohlenhydraten dar, wobei die Proteine mit ca. 90% den Hautpanteil ausmachen. Bei Wasserzugabe bildet Gluten eine gummiartige, elastische Masse, und hat daher für die Herstellung von Teig sowie für die Backeigenschaften von Mehl eine zentrale Bedeutung.Gluten is a gluten-based white that is found in wheat, rye, barley, oat and spelled flour and in the related cereals. It is a mixture of proteins, lipids and carbohydrates, whereby the protein accounts for about 90% of the Hautpanteil. When water is added, gluten forms a rubbery, elastic mass, and therefore has a central importance for the production of dough and for the baking properties of flour.
Gluten ist als Mehlbestandteil in vielen alltäglichen Lebensmitteln enthalten, und ist das auslösende Element für verschieden stark ausgeprägte Unverträglichkeiten bis hin zur Zöliakie. Damit verbunden sind immunologische Reaktionen sowie entzündliche Prozesse, die die Darmschleimhaut schädigen und zerstören können. Bei normaler Verdauung ist Gluten ungefährlich, aber bei glutenempfindlichen Menschen wird die Dünndarmschleimhaut derart geschädigt, dass keine normale Verdauung mehr möglich ist. Typische Anzeichen für eine Glutenunverträglichkeit sind Blähungen, Übelkeit, Bauchschmerzen, Appetitlosigkeit, chronischer Durchfall, und eine Gedeihstörung bei Kindern. Aktuelle Studien zeigen, dass die Häufigkeit für Zöliakie in den USA heute viermal so häufig ist wie vor 50 Jahren.Gluten is included as a flour component in many everyday foods, and is the triggering element for various degrees of intolerance to celiac disease. Associated with this are immunological reactions and inflammatory processes that can damage and destroy the intestinal mucosa. With normal digestion gluten is not dangerous, but in people sensitive to gluten, the small intestinal mucous membrane is damaged in such a way that normal digestion is no longer possible. Typical signs of gluten intolerance are flatulence, nausea, abdominal pain, loss of appetite, chronic diarrhea, and failure to thrive in children. Recent studies show that the incidence of celiac disease in the United States is four times higher today than it was 50 years ago.
Auch gibt es wissenschaftlichen Studien zufolge einen Zusammenhang zwischen glutenhaltiger Ernährung und der Entwicklung von Autoimmunantikörpern, die zur Ausbildung eines Diabetes mellitus Typ I führen. Neben der Glutenunverträglichkeit durch den häufigen und alltäglichen Genuss vieler mehlhaltiger Speisen können daher auch der zu hohe Anteil an Kohlenhydraten und ein zu geringer Anteil an Ballaststoffen weitere Probleme, wie Diabetes mellitus oder neuro-degenerative Erkrankungen verursachen.There are also scientific studies linking gluten-containing diets to the development of autoimmune antibodies that lead to the development of Type I diabetes mellitus. In addition to the gluten intolerance due to the frequent and everyday enjoyment of many meals containing flour, therefore, too high a proportion of carbohydrates and too low a proportion of dietary fiber can cause further problems such as diabetes mellitus or neuro-degenerative diseases.
Die bisher einzig mögliche Therapie ist eine lebenslang einzuhaltende Diät, bei der auf glutenhaltige Lebensmittel verzichtet wird. Bei vollständigem Verzicht auf glutenhaltige Lebensmittel bilden sich die Symptome nach einiger Zeit zurück.So far, the only possible therapy is a life-long diet, which dispenses with gluten-containing foods. If you completely refrain from gluten-containing foods, the symptoms return after some time.
Da Brot nicht nur in den Industrieländern bei der Ernährung eine große Rolle spielt wäre eine Brotzusammensetzung wünschenswert, die im Geschmack und in der Konsistenz einem glutenhaltigen Brot ähnelt. Aktuelle Studien zeigen, dass bspw. in Deutschland u. a. Brot die Hauptquelle für Protein ist. Im Allgemeinen ist es aber schwierig, Brot unter Einsatz von glutenfreien Getreidemehlen, wie bspw. Reismehl und Buchweizenmehl, herzustellen. Wenn der Teig mit Hefe fermentiert wird, wird bei Teigen, die glutenhaltiges Weizen- oder Roggenmehl enthalten, das durch die Fermentation erzeugte Kohlendioxidgas durch das Gluten gehalten, so dass das Glutennetzwerk ausgedehnt, wird und der Teig aufgeht. Umgekehrt, also wenn Teig mit glutenfreiem Mehl eingesetzt wird, kann das Kohlendioxidgas nicht gehalten werden, und der Teig geht nicht oder nur unzureichend auf.Since bread plays a major role in nutrition not only in the industrialized countries, it would be desirable to have a bread composition which resembles, in terms of taste and consistency, a gluten-containing bread. Recent studies show that, for example, in Germany u. a. Bread is the main source of protein. In general, however, it is difficult to produce bread using gluten-free cereal flours, such as rice flour and buckwheat flour. When the dough is fermented with yeast, in doughs containing gluten-containing wheat or rye flour, the carbon dioxide gas produced by the fermentation is held by the gluten, so that the gluten network expands, and the dough rises. Conversely, if dough with gluten-free flour is used, the carbon dioxide gas can not be held, and the dough is not or insufficiently on.
Im Stand der Technik sind ferner glutenfreie Teigzusammensetzungen bekannt, die als Grundlage für Brot und andere Nahrungsmittelprodukte eingesetzt werden sollen. So ist bspw. aus der
Wünschenswert sind daher glutenfreie Lebensmittel, die eine ähnliche Konsistenz wie Ihre glutenhaltigen Pendants aufweisen, und gleichzeitig keine anderen, gesundheitsschädlichen Nebenwirkungen haben.Gluten-free foods that are similar in consistency to your gluten-containing counterparts and have no other harmful side effects are therefore desirable.
Aufgabe der vorliegenden Erfindung ist es daher, eine neue Zusammensetzung für glutenfreie Nahrungsmittel bereitzustellen, die die Nachteile des Standes der Technik überwindet, und mit der die Lebensmittel in Ihrer Konsistenz, Geschmack und Herstellung den entsprechenden, glutenhaltigen Lebensmitteln nahekommen.It is therefore an object of the present invention to provide a novel composition for gluten-free foods which overcomes the disadvantages of the prior art and which approximates the food in its consistency, taste and manufacture to the corresponding gluten-containing food.
Erfindungsgemäß wird diese Aufgabe durch die Bereitstellung einer Zusammensetzung gelöst, die folgende Inhaltsstoffe aufweist:
Mehl und/oder Kleie aus zumindest einer glutenfreien Pflanze, ein auf Soja, Hafer und/oder Flohsamen basierendes Ballaststoffpulver, vorzugsweise SolaGrainTM,
Ölsaaten und/oder Kerne und/oder Nüsse in zerkleinerter Form, Presskuchen von Ölsaaten und/oder Kernen und/oder Nüssen,
und dass sie folgendes Nährstoffprofil aufweist:
Flour and / or bran from at least one gluten-free plant, a fiber powder based on soy, oats and / or psyllium, preferably SolaGrain ™ ,
Oilseeds and / or kernels and / or nuts in crushed form, presscakes of oilseeds and / or kernels and / or nuts,
and that it has the following nutrient profile:
Ferner wird die Aufgabe durch eine Back- oder Teigware gelöst, die ausgehend von der Zusammensetzung gemäß der Erfindung hergestellt wird, sowie durch die Verwendung der Zusammensetzung/der Back-/Teigwaren zur Behandlung von Erkrankungen wie Diabetes mellitus Typ-2, Alzheimer, Tumoren mit erhöhtem Zuckerstoffwechsel.Furthermore, the object is achieved by a baking or pasta product, which is prepared from the composition according to the invention, as well as by the use of the composition / the baking / pasta for the treatment of diseases such as diabetes mellitus type 2, Alzheimer's, tumors with increased sugar metabolism.
Die der Erfindung zugrunde liegende Aufgabe wird dadurch vollkommen gelöst.The object underlying the invention is thereby completely solved.
Mit der erfindungsgemäßen Zusammensetzung wird eine Basis für Nahrungsmittel, insbesondere für Back- und Teigwaren, bereitgestellt, die die Herstellung von glutenfreien, auf natürlichen Ausgangsstoffen beruhenden Gütern ermöglicht. Die erfindungsgemäße Zusammensetzung ist glutenfrei, kohlenhydratarm, protein- und fettbetont, sowie reich an Ballast- und sekundären Pflanzenstoffen.The composition of the present invention provides a base for foods, particularly bakery and pasta, which enables the production of gluten-free, natural-based goods. The composition of the invention is gluten-free, low in carbohydrates, protein and fat, and rich in ballast and phytochemicals.
Ferner stellt die erfindungsgemäße Zusammensetzung, sowie hieraus gefertigte Back- und Teigwaren vorteilhafterweise eine rein pflanzliche Proteinquelle dar, und besitzt gerade dadurch auch den hohen Ballaststoffgehalt. Das Risiko zur Entwicklung von Diabetes Typ-2, und darüber hinaus auch Bluthochdruck, kann durch den regelmäßigen Verzehr der erfindungsgemäßen Zusammensetzung in den damit gefertigten Back-/Teigwaren daher gesenkt werden.Furthermore, the composition according to the invention, as well as bakery and pasta products produced therefrom, advantageously constitute a purely vegetable protein source, and precisely because of this it also has the high fiber content. The risk of developing diabetes type 2, and moreover hypertension, can therefore be reduced by the regular consumption of the composition according to the invention in the baked / pasta products made therewith.
Dabei wird vorliegend unter ”Mehl” jedes aus einer Pflanze, insbesondere aus Getreide/Pseudogetreide(-körnern) gewonnene, pulverförmige Produkt eines Mahlvorgangs verstanden, bei dem die Pflanze oder, Teile davon, bspw., falls vorhanden, die hiervon stammenden Körner oder Samen, mahlend zerkleinert werden. Über den Mahlgrad kann in der Regel die Konsistenz und das Feuchtigkeitsbindungsvermögen gesteuert werden.In the present case, "flour" is understood to mean any pulverulent product of a milling process obtained from a plant, in particular from cereal / pseudo cereals (grains), in which the plant or, parts thereof, for example, if present, the grains or seeds derived therefrom , grinding crushed. About the degree of grinding can be controlled in the rule, the consistency and the moisture-binding capacity.
Unter ”Kleie” werden vorliegend die insbesondere bei der Getreideverarbeitung nach Absieben des Mehles zurückbleibenden Produkt-Rückstände aus Schalen, insbesondere Samenschale, Fruchtschale, verstanden. Kleie ist daher überwiegend ein Ballaststofflieferant und besteht hauptsächlich aus den Nichtstärke-Kohlenhydraten Cellulose, Hemicellulose und Lignin. Kleie enthält daher quellfähige und schleimbildende Bestandteile (β-D-Glucan, Arabinoxylane), die dafür sorgen, dass der Blutzuckeranstieg nach Stärkeaufnahme verzögert wird.In the present case, "bran" is understood to mean the product residues from shells, in particular seed coat, fruit peel, remaining in particular during grain processing after sieving off the flour. Bran is therefore predominantly a fiber source and consists mainly of the non-starch carbohydrates cellulose, hemicellulose and lignin. Bran therefore contains swellable and mucus-forming constituents (β-D-glucan, arabinoxylans), which cause the blood sugar increase after starch intake to be delayed.
Unter ”Ölsaaten” werden vorliegend Pflanzensamen bezeichnet, die u. a. auch zur Gewinnung von Pflanzenöl genutzt werden können. Zu den Ölsaaten zählen u. a. Soja, Raps, Hanf, Flachs, etc., mithin also jede Pflanze, deren Samen zur Ölgewinnung geeignet ist. Die Samen können im Ganzen oder als Ölschrot eingesetzt werden. Dabei werden als ”Ölschrot” die bei der Verarbeitung von Ölsaaten und – früchten neben dem Öl gewonnenen Koppelprodukte bezeichnet. Je nach Verarbeitungsverfahren werden sie auch Presskuchen (bei Heiß- oder Kaltpressung der Ölsaaten) oder Extraktionsschrot (bei Ölextraktion durch Lösungsmittel) genannt. Ölsaaten, Kerne und Nüsse zeichnen sich durch einen hohen Gehalt an essentiellen ungesättigten Fettsäuren und essentiellen Aminosäuren aus, und enthalten darüber hinaus auch Mineralien wie Magnesium, Selen oder Zink.Under "oilseeds" plant seeds are referred to here, the u. a. can also be used for the production of vegetable oil. The oilseeds include u. a. Soy, rapeseed, hemp, flax, etc., so any plant whose seeds are suitable for oil extraction. The seeds can be used whole or as oil meal. The term "oil meal" refers to the co-products obtained from the processing of oilseeds and fruits in addition to the oil. Depending on the processing method, they are also called press cake (in hot or cold pressing of the oilseeds) or extraction meal (in the case of oil extraction by means of solvents). Oil seeds, kernels and nuts are characterized by a high content of essential unsaturated fatty acids and essential amino acids, and also contain minerals such as magnesium, selenium or zinc.
Dementsprechend wird unter ”Presskuchen” das bei der Herstellung von Pflanzenöl nach dem Prinzip der Kaltpressung produzierte Koppelprodukt verstanden. Bestandteile des Presskuchens sind die nach der Pressung der Ölsaaten und -früchte verbleibenden Feststoffe und der nicht ausgepresste Ölanteil. Presskuchen ist ein mineralstoffreiches Produkt mit hohem Proteingehalt, und weist im Unterschied zu Extraktionsschrot einen hohen Fettgehalt auf.Accordingly, "press cake" is understood as the by-product produced in the production of vegetable oil according to the principle of cold pressing. Components of the presscake are the solids remaining after pressing of the oilseeds and fruits and the unpressed oil content. Press cake is a high-protein, high-mineral-rich product, and has a high fat content, in contrast to extraction meal.
Eine ”Nuss” ist vorliegend als eine runde bis ovale Frucht mit harter holziger Schale zu verstehen, die einen ölhaltigen, meist essbaren Kern umschließt; ferner ist unter ”Kern” der feste, innere Teil einer Frucht zu verstehen. A "nut" is to be understood here as a round to oval fruit with a hard woody shell, which encloses an oily, mostly edible core; furthermore, "core" is to be understood as meaning the solid, inner part of a fruit.
In einer Ausführungsform ist dabei bevorzugt, wenn die Pflanze ein Getreide oder Pseudogetreide ist.In one embodiment, it is preferred if the plant is a cereal or pseudo-cereal.
”Getreide” bedeuten vorliegend Pflanzen der Familie der Süßgräser (Poaceae = alle echten Getreidearten), die wegen ihrer Körnerfrüchte kultiviert werden. Sie bestehen aus dem stärke- und in geringerem Umfang teilweise auch eiweißhaltigen Mehlkörper, dem fetthaltigen Keimling, den miteinander verwachsenen Samenschale und Fruchtwand sowie der zwischen Mehlkörper und Schale liegenden eiweißhaltigen Aleuronschicht.In the present case, "cereals" mean plants of the grasses family (Poaceae = all true cereals), which are cultivated for their cereal crops. They consist of starch and, to a lesser extent, partially proteinaceous body of flour, the greasy seedling, the intergrown seed coat and pericarp, and the proteinaceous aleurone layer between the meal body and the shell.
Unter ”Pseudogetreide” werden vorliegend und im Allgemeinen Pflanzen mit Körnerfrüchten verstanden, die nicht zur Familie der Süßgräser gehören. Die Früchte sind meist sehr reich an Stärke, Eiweiß, Mineralstoffen und Fett.By "pseudo-cereals" is meant herein and generally plants with grain crops which do not belong to the family of sweet grasses. The fruits are usually very rich in starch, protein, minerals and fat.
Unter einem auf ”Soja, Hafer und/oder Flohsamen basierenden Ballaststoffpulver” wird vorliegend jede pulverförmige Zusammensetzung verstanden, die als Haupt- bzw. größten Bestandteile Sojaprotein (exträkte) und Sojaballaststoffe und/oder Haferballaststoffe und/oder Flohsamen – in extrahierter, gemahlener oder sonstigen Form – enthält, wobei es sich versteht, dass das Ballaststoffpulver noch weitere Inhaltsstoffe aufweisen kann, die der grundsätzlichen Eigenschaft des Pulvers als Ballaststofflieferant nicht abträglich sind.Under a "soy, oats and / or psyllium-based fiber powder" is in the present case any powdered composition understood as the main or largest components soy protein (exträkte) and soybean and / or oat fiber and / or psyllium - in extracted, ground or other Form - contains, it being understood that the fiber powder may contain other ingredients that are not detrimental to the basic property of the powder as a fiber supplier.
Ein bevorzugtes Ballaststoffpulver stellt SolaGrainTM dar, das die Bezeichnung eines käuflich erhältlichen proteinreichen Ballaststoff-Pulvers ist, das folgende Inhaltsstoffe aufweist: Sojaproteinextrakt, Haferballaststoffe, Sojaballaststoffe, Flohsamen, Maltodextrin, Leinsamenballaststoffe, Rübenballaststoffe, Leinsamenprotein, Zellulose, Guarkernmehl und Lecithin. Die Verwendung von SolaGrainTM bietet den Vorteil, dass der Mehlanteil und auch der Kohlenhydratanteil gezielt reduziert werden kann, während Ballaststoff- und Proteinanteile gesteigert sowie Backeigenschaften und Wasserverbindungsvermögen der Zusammensetzung positiv beeinflusst werden.A preferred fiber powder is SolaGrain ™ , which is the name of a commercially available high protein fiber powder comprising soybean protein extract, oat fiber, soybean fiber, psyllium seed, maltodextrin, linseed dietary fiber, beet pulp, linseed protein, cellulose, guar gum and lecithin. The use of SolaGrain TM has the advantage that the flour content and the carbohydrate content can be reduced in a targeted manner, while fiber and protein content are increased and the baking properties and water-binding properties of the composition are positively influenced.
Es versteht sich, dass auch jedes andere Ballaststoffpulver, das so ähnlich wie oder wie SolaGrainTM zusammengesetzt ist und die gleichen oder sehr ähnliche Eigenschaften aufweist, im Sinne der vorliegenden Erfindung eingesetzt werden kann, wobei dem Fachmann klar sein wird, dass leichte Veränderungen der Zusammensetzung des Ballaststoffpulvers möglich sind, die dennoch im Rahmen der vorliegenden Erfindung liegen.It is understood that any other fiber powder, which is similar or as SolaGrain TM and has the same or very similar properties, can be used in the context of the present invention, it being understood by those skilled in the art that slight changes in the composition the fiber powder are possible, which are still within the scope of the present invention.
Auch der Einsatz von Presskuchen bietet herausragende Vorteile: Presskuchen wurden und werden im Stand der Technik bspw. in Tierfutter verarbeitet (Kürbiskern-Presskuchen) oder als organischer Dünger dem Boden wieder zugeführt (Traubenkern-Presskuchen). Der erfindungsgemäße Einsatz von Presskuchen ermöglicht es, auszunutzen, dass diese einen Fettgehalt von ca. 10% aufweisen, aber an wertvollen Omega-3-Fettsäuren abgesättigt sind. Der Proteingehalt kann dabei über 40% betragen, sowie der Ballaststoffgehalt fast 60%.The use of press cake offers outstanding advantages: press cakes were and are processed in the art, for example, in animal feed (pumpkin seed press cake) or returned to the soil as an organic fertilizer (grape seed press cake). The use of press cake according to the invention makes it possible to exploit the fact that they have a fat content of about 10%, but are saturated with valuable omega-3 fatty acids. The protein content can be over 40%, and the fiber content almost 60%.
Die erfindungsgemäße Zusammensetzung zeichnet sich ferner durch einen hohen Eiweißgehalt, einem niedrigen Kohlenhydratanteil und einem hohen Teil an Ballaststoffen aus. Ferner wird durch die erfindungsgemäße Zusammensetzung erstmals ein glutenfreies Ausgangsprodukt bereitgestellt, über das glutenfreie Back- und Teigwaren hergestellt werden können, die in ihrer Konsistenz und geschmacklich glutenhaltigen Back- und Teigwaren sehr nahekommen. Ferner basiert die vorliegende Zusammensetzung ganz auf natürlichen Inhaltsstoffen, was neben den oben erwähnten Eigenschaften auch zur besseren Verträglichkeit und Akzeptanz durch die betreffenden Verkehrskreise führt.The composition of the invention is further characterized by a high protein content, a low carbohydrate content and a high content of dietary fiber. Furthermore, the gluten-free starting product is provided by the composition of the invention for the first time, can be made on the gluten-free bakery and pasta, which come very close in their consistency and flavor gluten-containing bakery and pasta. Furthermore, the present composition is based entirely on natural ingredients, which in addition to the above-mentioned properties also leads to better compatibility and acceptance by the relevant public.
In einer weiteren vorteilhaften Ausführungsform ist die glutenfreie Pflanze ausgewählt aus Buchweizen, Quinoa, Amaranth, Mais, Reis, Hirse, (Wild)-Reis, Soja, Teff, Sorghum.In a further advantageous embodiment, the gluten-free plant is selected from buckwheat, quinoa, amaranth, maize, rice, millet, (wild) rice, soy, teff, sorghum.
Buchweizen, Amaranth und Quinoa sind die bekanntesten Vertreter der Pseudogetreide, bilden jedoch ähnlich wie Getreide stärkehaltige Körner aus. Die Samen dieser Pseudogetreide können wie Getreidekörner verarbeitet werden, enthalten aber kein Gluten, weshalb sich mit reinen Mehlen aus Körnern dieser Pflanzen keine Teige wie mit Mehl aus Weizen oder Roggen hergestellt werden können. Erst durch Kombination mit den weiteren, in der erfindungsgemäßen Zusammensetzung enthaltenden Inhaltsstoffen, die aber sämtlich glutenfrei sind, lassen sich Back-/Teigwaren herstellen, die in ihrer Konsistenz und auch im Geschmack mit glutenhaltigen Back-/Teigwaren vergleichen lassen.Buckwheat, amaranth and quinoa are the most well-known representatives of pseudo-cereals, but like cereals they form starchy grains. The seeds of these pseudo-cereals can be processed like cereal grains, but contain no gluten, which is why with pure flours from grains of these plants no doughs can be produced as with flour from wheat or rye. Only by combination with the other, containing in the composition of the invention ingredients, but all are gluten-free, baking / pasta can be produced, which can be compared in their consistency and in taste with gluten-containing bakery / pasta.
Ferner ist bevorzugt, wenn das Mehl der Pflanze, insbesondere vorzugsweise des Getreide/Pseudogetreide, in einem Teig, vorzugsweise einem Sauerteig, verarbeitet ist. Dabei ist bevorzugt, wenn das Mehl Buchweizenvollkornmehl ist; in einer weiteren Ausführungsform ist bevorzugt, wenn ein Sauerteig aus Buchweizenvollkornmehl mit Wasser, Maismehl, Erbsenmehl und Honig angesetzt ist.It is further preferred if the flour of the plant, in particular preferably the cereal / pseudo cereal, is processed in a dough, preferably a sourdough. It is preferred if the flour is buckwheat whole grain flour; in a further embodiment it is preferred if a sourdough made of buckwheat whole grain flour with water, maize flour, pea flour and honey is used.
In einer weiteren Ausführungsform ist bevorzugt, wenn die Ölsaaten, Kerne oder Nüsse ausgewählt sind aus Leinsamen, Hanfsamen, Sesamsamen, Kürbiskerne, Sonnenblumenkerne, Traubenkerne, Granatapfelkerne, Buchweizennüsschen, Flohsamen.In another embodiment, it is preferred if the oilseeds, kernels or nuts are selected from linseeds, hemp seeds, sesame seeds, pumpkin seeds, sunflower seeds, grape seeds, pomegranate seeds, buckwheat nectar, psyllium.
Insbesondere ist dabei bevorzugt, wenn die Zusammensetzung folgendes aufweist:
ca. 9% Hanfsamen
ca. 6% Leinsamen
ca. 6% Sesam
ca. 5% Kürbiskernmehl und/oder Buchweizenmehl
ca. 2% Traubenkernmehl
ca. 1% Granatapfelkernmehl In particular, it is preferred if the composition has the following:
about 9% hemp seeds
about 6% linseed
about 6% sesame
about 5% pumpkin seed flour and / or buckwheat flour
about 2% grape seed flour
about 1% pomegranate seed flour
Diese Ölsaaten können dabei geschält oder ungeschält, zerkleinert, gemahlen, entölt oder gepresst oder in ganzer Form vorliegen. Dabei ist weiter bevorzugt, wenn insbesondere die Hanfsamen in geschälter Form vorliegen.These oilseeds can be peeled or unpeeled, ground, ground, de-oiled or pressed or in whole form. It is further preferred if in particular the hemp seeds are present in peeled form.
Mit dieser Auswahl an Ölsaaten wird darüber hinaus auch gewährleistet, dass eine ausreichende bzw. hohe Versorgung mit Omega-3-Fettsäuren erfolgt. Omega-3-Fettsäuren sind für den Menschen essentiell und werden vom Körper nicht selber gebildet, weshalb sie mit der Nahrung aufgenommen werden müssen. Neuere Studien haben die gesundheitsfördernde Wirkung von Omega-3-Fettsäuren gezeigt, wie bspw. deren antithrombotische Wirkung, mit der Herz-Kreislauferkrankungen vorgebeugt werden kann. Darüber hinaus werden Omega-3-Fettsäuren für die Entwicklung der Gehirn- und Sehleistung benötigt. Auch konnte für Omega-3-Fettäsuren eine gesundheitsfördernde Wirkung bei rheumatischen Erkrankungen gezeigt werden, da aus ihnen gebildete Stoffe eine entzündungshemmende Wirkung entfalten.In addition, this selection of oilseeds ensures that there is a sufficient or high supply of omega-3 fatty acids. Omega-3 fatty acids are essential for humans and are not produced by the body itself, which is why they have to be ingested with food. Recent studies have shown the health benefits of omega-3 fatty acids, such as their antithrombotic effect, which can prevent cardiovascular disease. In addition, omega-3 fatty acids are needed for the development of brain and vision. For omega-3 fatty acids, a health-promoting effect on rheumatic diseases has also been shown, since substances formed from them have an anti-inflammatory effect.
Mit der erfindungsgemäßen Zusammensetzung wird somit eine gesundheitsfördernde Wirkung erzielt.Thus, a health-promoting effect is achieved with the composition according to the invention.
Es versteht sich, dass in der vorliegenden Anmeldung mit der Angabe ”ca.” gemeint ist, dass nicht exakt die angegebenen prozentualen Anteile in der Zusammensetzung vorliegen müssen, sondern dass auch leichte Abweichungen von den Zahlenangeben nach oben oder unten zu verstehen sind, die damit sowohl per se vom Fachmann verstanden werden, als auch von diesem als zum Schutzbereich der vorliegenden Erfindung gehörend erkennbar sind.It is understood that in the present application the term "approximately" means that it is not necessary for the stated percentage proportions to be present in the composition, but that slight deviations from the numbers above or below are to be understood both per se understood by those skilled in the art, as well as by this as belonging to the scope of the present invention are recognizable.
Darüber hinaus kann in anderen Ausführungsformen der erfindungsgemäßen Zusammensetzung bevorzugt sein, wenn weitere zusätzliche Inhaltsstoffe, die bei Back-/Teigwaren, insbesondere bei Broten oder Brot-ähnlichen Lebensmitteln üblich sind, in der Zusammensetzung eingesetzt werde, wie bspw. Wasser, Früchte, Vitamine, Salz, natürliche Süßungsmittel, wie bspw. Honig oder Stevia, etc. Dem Fachmann wird klar sein, dass, je nach dem, für welche Zielgruppe/bei welchen Erkrankungen die Zusammensetzung eingesetzt werden soll, viele verschiedene Inhalts- oder Ergänzungsstoffe in unterschiedlichen Mengen beigefügt und miteinander kombiniert werden können.Moreover, in other embodiments of the composition according to the invention, it may be preferred if additional additional ingredients customary in bakery / pasta products, in particular breads or bread-like foods, are used in the composition, such as, for example, water, fruits, vitamins, Salt, natural sweeteners, such as honey or stevia, etc. It will be clear to the person skilled in the art that, depending on which target group / diseases the composition is to be used for, many different ingredients or supplements are added in different amounts and can be combined with each other.
Insbesondere ist in einer Ausführungsform bevorzugt, wenn die Zusammensetzung noch Wasser, Honig, Salz, insbesondere Meersalz, Sojalecithin aufweist.In particular, in one embodiment, it is preferred if the composition also contains water, honey, salt, in particular sea salt, soya lecithin.
Als weitere glutenfreie Komponenten für die Mehle, Ölsamen/Ölsaaten, Nüsse/Körner, Presskuchen oder als Zutat in der Zusammensetzung können zur Herstellung besonderer, glutenfreier Produkte ferner die folgenden eingesetzt werden: Beeren, Eier, Fisch (Kaltwasser, Omega-3-reich), Fleisch, Gemüse, Gewürze, Grüntee, Hülsenfrüchte, Kartoffel, Kakao, Kräuter, Hartkäse, Kastanien, Kichererbsen, Knoblauch, Kokosnuss(mehl), Kurbiskern(mehl), Mandel(mehl), Maniok, vergorene Milchprodukte, Obst, Oliven, Paranüsse, Pilze, Sorghum, Teff, Traubenkernmehl, Zwiebeln.As further gluten-free components for the flours, oilseeds / oil seeds, nuts / grains, press cake or as an ingredient in the composition, the following can also be used to produce special, gluten-free products: berries, eggs, fish (cold water, omega-3 rich) , Meat, vegetables, spices, green tea, legumes, potato, cocoa, herbs, hard cheese, chestnuts, chickpeas, garlic, coconut (flour), pumpkin seeds (flour), almond (flour), cassava, fermented milk products, fruit, olives, Brazil nuts , Mushrooms, sorghum, teff, grapeseed flour, onions.
Ferner ist in weiteren Ausführungsformen bevorzugt, wenn die Zusammensetzung weitere natürliche sekundäre Pflanzenstoffe aufweist, die ausgewählt sind aus Glucosinolate, Carotinoide, Lektine, Flavonoide, Phytosterine, Polyphenolen, und genauer aus Curcumin, Ellagsäure, Quercetin, Resveratrol, Delphinidin, Diallylsulfid, Epigallocatechin-3-gallat, Genistein, Indol-3-carbinol, Isoterpene, Limonin, Lycopin, OPC, Salvestrole, Sulforaphan, Ubichinon. Further, in further embodiments, it is preferred that the composition comprises other natural phytochemicals selected from glucosinolates, carotenoids, lectins, flavonoids, phytosterols, polyphenols, and more particularly curcumin, ellagic acid, quercetin, resveratrol, delphinidin, diallyl sulfide, epigallocatechin-3 gallate, genistein, indole-3-carbinol, isoterpenes, limonin, lycopene, OPC, salvestrols, sulforaphane, ubiquinone.
Sekundäre Pflanzenstoffe (SPS) besitzen neueren Erkenntnissen zufolge eine bedeutende Wirksamkeit, insbesondere bei chronischen Entzündungen und Mitochondrienschädigungen sowie bei onkologischen Erkrankungen. Bevorzugt ist hierbei, dass die sekundären Pflanzenstoffe nicht isoliert oder naturidentisch zugesetzt werden, sondern bereits als Bestandteil der weiteren natürlichen Zutaten enthalten sind.According to recent findings, secondary plant compounds (SPS) have a significant efficacy, in particular in the case of chronic inflammation and mitochondrial damage as well as oncological diseases. It is preferred here that the secondary plant substances are not added in isolation or identical to nature, but are already present as part of the further natural ingredients.
In einer weiteren Ausführungsform ist bevorzugt, wenn die Zusammensetzung einen Omega-3-Fettsäuren-Gehalt von ca. 1% bis ca. 3% aufweist und dass das Verhältnis von Omega-6-Fettsäure zu Omega-3-Fettsäure in der Zusammensetzung max. 5:1 ist.In another embodiment, it is preferred if the composition has an omega-3 fatty acid content of about 1% to about 3% and that the ratio of omega-6 fatty acid to omega-3 fatty acid in the composition is max. 5: 1 is.
Omega-6-Fettsäuren sind wie Omega-3-Fettsäuren ungesättigte Fettsäuren, die für den Menschen essentiell sind. Da Linolsäure als Vertreter der Omega-6-Fettsäuren und Alpha-Linolensäure als Vertreter der Omega-3-Fettsäuren teilweise gegensätzliche Wirkungen im menschlichen Körper haben und bei der Synthese der höherwertigen ungesättigen Fettsäuren konkurrieren, sollte die Zufuhr von Linolsäure und Alpha-Linolensäure vorzugsweise im Verhältnis von 5:1 erfolgen.Like omega-3 fatty acids, omega-6 fatty acids are unsaturated fatty acids that are essential for humans. Since linoleic acid, as a representative of omega-6 fatty acids and alpha-linolenic acid as a representative of omega-3 fatty acids, have partially opposite effects in the human body and compete in the synthesis of higher-value unsaturated fatty acids, the supply of linoleic acid and alpha-linolenic acid should preferably be in the Ratio of 5: 1 done.
Die erfindungsgemäße Zusammensetzung ist bevorzugt laktosefrei, nitritfrei, milcheiweißfrei, hefefrei und frei von Konservierungsstoffen.The composition according to the invention is preferably lactose-free, nitrite-free, milk-protein-free, yeast-free and preservative-free.
In einer weiteren bevorzugten Ausführungsform wird anstelle des pflanzlichen Materials, das in Form von Mehl oder Kleie bereitgestellt wird, auf Fleisch oder Pilze zurückgegriffen, wobei das Fleisch irgendein Fleisch sein kann, wie bspw. Schweine-, Kalb-, Rind-, Pferde-, Fisch-, Schaf-, Ziegenfleisch, Geflügelfleisch, etc., und die Pilze aus jedem essbaren Pilz ausgewählt sein können, insbesondere aus Champignons, Steinpilzen, Pfifferlingen, Austerpilzen, Morcheln, Shiitake, etc., wobei die vorgenannten lediglich Beispiele darstellen sollen, und dem Fachmann klar ist, dass jedes essbare Fleisch und jeder essbare Pilz im Rahmen der vorliegenden Erfindung geeignet sein kann.In a further preferred embodiment, instead of the vegetable material provided in the form of flour or bran, meat or mushrooms are used, the meat being any meat, such as pork, veal, beef, horse, Fish, sheep, goat meat, poultry meat, etc., and the mushrooms may be selected from any edible fungus, in particular from mushrooms, porcini mushrooms, chanterelles, oyster mushrooms, morels, shiitake, etc., the above merely being examples, and It will be understood by those skilled in the art that any edible meat and edible fungus may be useful in the present invention.
Die vorliegende Erfindung betrifft, wie bereits weiter oben erwähnt, auch Back- oder Teigwaren, die ausgehend von einer erfindungsgemäßen Zusammensetzung hergestellt sind, bspw. und insbesondere Brot, brotähnliche Nahrungsmittel, Gebäck, Kekse, Kuchen, Pizza, Nudeln, Riegel, Snacks, oder Riegel- und Snack-ähnliche Produkte, wobei unter Riegel oder Snack jedes Produkt verstanden wird, das in Form einer Essensration als Zwischenmahlzeit geeignet ist, gleich welcher Form.The present invention also relates, as already mentioned above, to baked goods or pasta which are produced from a composition according to the invention, for example bread and bread-like foods, pastries, biscuits, cakes, pizzas, noodles, bars, snacks, or Bar-type and snack-like products, where bar or snack is understood to mean any product suitable as a snack in the form of a food ration, whatever its shape.
Die genannten erfindungsgemäßen Inhaltsstoffe werden gemäß bestimmten, variierbaren Anteilen kombiniert, mit Wasser vermengt und im Falle von Backwaren gebacken.The said ingredients according to the invention are combined according to certain variable proportions, mixed with water and baked in the case of baked goods.
Dabei kann insbesondere vorgesehen sein, dass zunächst Buchweizennatursauerteig hergestellt wird, bspw. aus Buchweizenvollkornmehl, Wasser, Maismehl, Erbsenmehl, Honig, und dieser Ansatz nach einer bestimmten Ruhezeit (bspw. über Nacht) mit den weiteren Inhaltstoffen kombiniert und der gesamte Ansatz gebacken wird.It may in particular be provided that buckwheat natural sourdough is first prepared, for example from buckwheat wholemeal flour, water, maize flour, pea flour, honey, and this approach is combined with the further ingredients after a certain period of rest (for example overnight) and the entire batch is baked.
Daher betrifft die vorliegende Erfindung auch ein Verfahren zur Herstellung einer Backware, wie vorliegend beansprucht und offenbart, das die folgenden Schritte aufweist:
- – Herstellen eines Natursauerteiges basierend auf Mehl einer glutenfreiem Pflanze, vorzugsweise Getreide-/Pseudogetreidemehl, vorzugsweise Buchweizenvollkornmehl,
- – Ruhenlassen dieses Natursauerteiges für mindestens 8 Stunden,
- – Vermengen des Natursauerteiges mit den weiteren erfindungsgemäßen Inhaltsstoffen zur Herstellung einer erfindungsgemäßen Zusammensetzung,
- – Backen der Zusammensetzung bei 140°C bis 180°C,
- Preparing a natural sourdough based on flour of a gluten-free plant, preferably cereal / pseudo-wheat flour, preferably buckwheat whole-wheat flour,
- - leaving this natural sour dough for at least 8 hours,
- Blending the natural sour dough with the other ingredients according to the invention to produce a composition according to the invention,
- Baking the composition at 140 ° C to 180 ° C,
Ferner betrifft die vorliegende Erfindung auch die Verwendung einer erfindungsgemäßen Zusammensetzung und/oder des hieraus hergestellten Produktes wie bspw. Back-/Teigwaren als Mittel zur therapeutischen oder präventiven Behandlung von Krankheiten, die ausgewählt sind aus Zöliakie, Diabetes mellitus Typ-2, neurodegenerative Krankheiten, insbesondere Alzheimer, Tumorerkrankungen, sowie Erkrankungen, die zu einer Kachexie (Auszehrung) führen, die mit entzündlichen Prozessen einhergehen oder davon verursacht werden, insbesondere Rheuma, rheumatoide Arthritis, entzündliche Darmerkrankungen wie Ulzerative Colitis, Morbus Crohn, Darmerkrankungen wie das Leaky-Gut-Syndrom (durchlässiger Darm).Furthermore, the present invention also relates to the use of a composition according to the invention and / or the product produced therefrom, such as bakery / pasta as an agent for the therapeutic or preventive treatment of diseases selected from celiac disease, diabetes mellitus, etc. 2, neurodegenerative diseases, in particular Alzheimer's disease, tumors, as well as diseases leading to cachexia associated with or caused by inflammatory processes, in particular rheumatism, rheumatoid arthritis, inflammatory bowel diseases such as ulcerative colitis, Crohn's disease, intestinal diseases such as Leaky gut syndrome (permeable bowel).
Bei der erfindungsgemäßen Verwendung wird einem menschlichen Patienten eine entsprechende therapeutische Menge der basierend auf der erfindungsgemäßen Zusammensetzung hergestellten Produkte verabreicht, wobei die Menge und der Verabreichungsplan von dem Patienten selber, insbesondere dessen Verfassung, sowie der zu behandelnden/vorzubeugenden Krankheit abhängt, wobei des im Können und Wissen der behandelnden Person liegt, wie die Dosierungen und Verabreichungspläne erstellt werden müssen, um einen Erfolg bei der Behandlung bzw. in der Prävention erzielen zu können.In the use according to the invention, a human patient is administered a corresponding therapeutic amount of the products prepared based on the composition of the invention, the amount and administration schedule being dependent on the patient himself, especially on his condition, as well as the disease to be treated / prevented and the knowledge of the treating person as to how the dosages and administration schedules have to be created in order to be successful in treatment or prevention.
Mit der erfindungsgemäßen Verwendung kann eine therapeutische oder präventive Behandlung von Personen erfolgen, die entweder von einer genannten Erkrankungen betroffen sind, oder aber die – entweder genetisch oder ernährungstechnisch bedingt – das Risiko tragen, solche Krankheiten zu entwickeln.With the use according to the invention, a therapeutic or preventive treatment can be carried out by persons who are either affected by said diseases or who - either genetically or nutritionally conditioned - carry the risk of developing such diseases.
Auch bereits durch die Kombination aus einem hohem Omega-3-Fettsäurenanteil und einem niedrigen Kohlenhydratanteil kann eine positive Wirkung bei den genannten Erkrankungen erreicht werden. Da die Zusammensetzung in Form von Brot oder ähnlichen Backwaren bereitgestellt bzw. verarbeitet werden kann, kann eine Verabreichung besonders einfach erfolgen.Even by the combination of a high omega-3 fatty acid content and a low carbohydrate content, a positive effect can be achieved in the aforementioned diseases. Since the composition can be provided or processed in the form of bread or similar baked goods, administration can be particularly easy.
So ist die erfindungsgemäße Zusammensetzung auch bei einem nachgewiesenen veränderten Glukose-Stoffwechsel als therapeutische Maßnahme von Vorteil. Bestimmte aggressive Krebszellen, die Glukose vergären statt sie zu verbrennen, decken ihren Energiebedarf ausschließlich mit Glukose, und können weder Fette noch Öle als weitere Energiequelle nutzen. Eine große Rolle bei diesem veränderten Stoffwechsel in Tumoren spielt das Enzym Transketolase-like 1 (TKTL1; Transketolase-ähnlich), das in den aggressiven Krebszellen stark exprimiert wird und entsprechend aktiv ist. Durch den niedrigen Kohlenhydratanteil in der erfindungsgemäßen Zusammensetzung wird eine niedrige Glukose-Freisetzung gewährleistet, wodurch in den Tumoren weniger Glukose vergärt und somit die Aktivität von TKTL1 herabgesetzt und dadurch das Wachstum von Tumoren gebremst werden kann.Thus, the composition according to the invention is also advantageous in the case of a proven altered glucose metabolism as a therapeutic measure. Certain aggressive cancer cells, which ferment glucose rather than burn it, use only glucose to cover their energy needs, and can not use fats or oils as another source of energy. A major role in this altered metabolism in tumors plays the enzyme transketolase-like 1 (TKTL1, transketolase-like), which is strongly expressed in the aggressive cancer cells and is accordingly active. The low carbohydrate content in the composition according to the invention ensures a low release of glucose, as a result of which less glucose is fermented in the tumors and thus the activity of TKTL1 is reduced and the growth of tumors can thereby be slowed down.
Ähnliches gilt für Diabetes mellitus-Patienten, da mit der erfindungsgemäßen Zusammensetzung auch hier gewährleistet ist, dass nur sehr wenig Glukose freigesetzt wird, was den Glukose-Anstieg im Blut von Diabetes-Patienten senkt. Dabei kann ferner die gleichzeitige Verabreichung von Vitamin B1 oder Vitamin B1-Derivate (bspw. Benfotiamin) in der Zusammensetzung vorgesehen sein, welches ein Cofaktor für Transketolase Enzyme darstellt. Dadurch wird das TKTL1-Enzym aktiviert, wodurch hyperglykämische Schäden verhindert werden. Damit wird auch die Bildung von AGEs (Advanced Glycation Endproducts; nicht-enzymatisch glykierte Endprodukte) herabgesetzt, also von Produkten, die bei Patienten mit Diabetes mellitus durch Glykosylierung von u. a. Proteinen entstehen. Daneben wird durch die Aktivierung des TKTL1-Enzyms die Bildung von ROS (reactive oxygen species; reaktive Sauerstoff-Derivate) vermindert, was zu einer verringerten Zellschädigung und Zellalterung („anti-aging”) führt.The same applies to diabetes mellitus patients, since it is ensured here with the composition according to the invention that only very little glucose is released, which lowers the glucose increase in the blood of diabetic patients. In addition, the simultaneous administration of vitamin B1 or vitamin B1 derivatives (for example benfotiamine) in the composition, which is a cofactor for transketolase enzymes, may be provided. This activates the TKTL1 enzyme, preventing hyperglycaemic damage. This also reduces the formation of AGEs (Advanced Glycation Endproducts), ie products that have been identified in patients with diabetes mellitus by glycosylation of u. a. Proteins arise. In addition, the activation of the TKTL1 enzyme reduces the formation of ROS (reactive oxygen species), resulting in reduced cell damage and cell aging ("anti-aging").
Auch bei neurodegenerativen Krankheiten wie der Alzheimer Krankheit kann die erfindungsgemäße Zusammensetzung als Mittel zur Therapie oder Prävention eingesetzt werden. So konnte bspw. bei der Alzheimer Krankheit gezeigt werden, dass der Glukose-Stoffwechsel und die Bildung von AGEs für diese Erkrankung und für das Altern überhaupt eine Rolle spielt, da AGEs bspw. in senilen Plaques vorliegen, die in großer Dichte in der grauen Hirnsubstanz von Alzheimer-Patienten gefunden werden. Mit der Kohlenhydrat-armen Zusammensetzung kann daher bei diesen Patienten ein vorteilhaftes Absenken des Glukosespiegels erreicht werden, so dass auch die Bildung von AGEs und deren Ablagerung in Plaques verhindert werden kann.Even in neurodegenerative diseases such as Alzheimer's disease, the composition according to the invention can be used as an agent for therapy or prevention. For example, it has been shown in Alzheimer's disease that glucose metabolism and the formation of AGEs play a role in this disease and in aging, since AGEs are present, for example, in senile plaques, which are present in high density in the gray matter be found by Alzheimer's patients. With the carbohydrate-poor composition, therefore, a favorable lowering of the glucose level can be achieved in these patients, so that the formation of AGEs and their deposition in plaques can be prevented.
Es versteht sich, dass die vorstehend genannten und nachstehend noch zu erläuternden Merkmale nicht nur in der jeweils angegebenen Kombination, sondern auch in anderen Kombinationen oder auch in Alleinstellung verwendbar sind, ohne den Rahmen der vorliegenden Erfindung zu verlassen.It is understood that the features mentioned above and those yet to be explained can be used not only in the respectively specified combination but also in other combinations or also alone, without departing from the scope of the present invention.
Eine Ausführungsform der Erfindung wird in dem nachstehenden Beispiel näher erläutert.An embodiment of the invention will be explained in more detail in the following example.
Herstellung von Brot Production of bread
Zur Herstellung einer Ausführungsform der erfindungsgemäßen Zusammensetzung sowie eines erfindungsgemäßen, auf der Zusammensetzung basierenden Produktes, nämlich eines Brots, wurde wie folgt vorgegangen:
Zunächst wurde Buchweizennatursauerteig, hergestellt aus Buchweizenvollkornmehl, Wasser, Maismehl, Erbsenmehl, Honig, her- und bereitgestellt, und der Ansatz für eine bestimmten Zeitdauer, bspw. über Nacht, d. h. für einen Zeitraum von zwischen 8 bis 16 Stunden, ruhen gelassen.To prepare an embodiment of the composition according to the invention and of a composition based on the product according to the invention, namely a bread, the procedure was as follows:
First, buckwheat natural sourdough prepared from whole buckwheat flour, water, corn flour, pea flour, honey, was prepared and provided, and allowed to rest for a certain period of time, eg overnight, ie for a period of between 8 to 16 hours.
Die weiteren Zutaten für die Zusammensetzung, nämlich Wasser, SolaGrainTM (Sojaproteinextrakt, Haferballaststoffe, Sojaballaststoffe, Flohsamen, Maltodextrin, Leinsamenballaststoffe, Rübenballaststoffe, Leinsamenprotein, Zellulose, Guarkernmehl und Lecithin), sowie 9% Hanfsamen, 6% Leinsamen, 6% Sesam, 5% Kürbiskernmehl und/oder Buchweizenmehl, 2% Traubenkernmehl, 1% Granatapfelkernmehl, Salz, Honig und Sojalecithin wurden mit dem im ersten Schritt hergestellten Buchweizennatursauerteig kombiniert und vermengt, für eine kurze Zeit ruhen gelassen und in eine offene Form gegeben. Dieser Ansatz wurde dann bei 160°C gebacken. Ferner wurde die erhaltene Backware noch in Folie abgepackt und pasteurisiert.The other ingredients of the composition, namely water, SolaGrain ™ (soy protein extract, oat fiber, soybean fiber, psyllium seed, maltodextrin, linseed, beet pulp, linseed protein, cellulose, guar gum and lecithin), as well as 9% hemp seed, 6% linseed, 6% sesame, 5 % Pumpkin seed flour and / or buckwheat flour, 2% grapeseed flour, 1% pomegranate kernel flour, salt, honey and soy lecithin were combined with the buckwheat natural sourdough prepared in the first step and blended, allowed to rest for a short time and placed in an open mold. This batch was then baked at 160 ° C. Furthermore, the baked goods were still packaged in foil and pasteurized.
Die Inhaltsstoffe des erhaltenen Brotes wurden bestimmt, und sind in der nachstehenden Tabelle 1 wiedergegeben: Tabelle 1: Durchschnittliche Nährwerte pro 100 g:
- * 70% der empfohlenen Tagesdosis
- * 70% of the recommended daily dose
Dem Beispiel ist zu entnehmen, dass das fertige Brot weniger als 18% Kohlenhydrate, mehr als 10% Fett und über 9% Ballaststoffe enthält. Insbesondere zeichnet sich das erfindungsgemäße Brot durch einen extrem hohen Anteil an (essentiellen) ungesättigten Fettsäuren, sowie auch durch einen sehr hohen Omega-3-Fettsäuren-Gehalt aus. Das erhaltene Brot ist somit im Rahmen eines diätetischen Ernährungsplans insbesondere für Diabetes mellitus Patienten sowie für Zöliakie-Patienten – und darüber hinaus für jede sich gesundheitsbewusst ernährende Person – geeignet.The example shows that the finished bread contains less than 18% carbohydrates, more than 10% fat and over 9% fiber. In particular, the bread according to the invention is characterized by an extremely high content of (essential) unsaturated fatty acids, as well as by a very high omega-3 fatty acid content. The resulting bread is thus in the context of a dietary nutrition plan in particular for diabetes mellitus patients and for celiac disease patients - and beyond for any health-nutritious person - suitable.
Mit der vorliegenden erfindungsgemäßen Zusammensetzung, d. h. der Kombination glutenfreier Komponenten von Mehlen/Kleien aus Getreiden/Gräsern oder getreideähnlichen Pflanzen wie Buchweizen, einem proteinreichen Ballaststoff-Pulver (SolaGrainTM), Ölsaaten/Kerne/Nüsse und Presskuchen von Ölsaaten/Kernen/Nüssen wird somit eine ausgewogene und ggf. therapeutische Aufnahme von Nähr- und Ballaststoffen in erwünschter Menge in der alltäglichen Ernährung durch das neuartige Lebensmittel ermöglicht. Dabei ist von besonderem Nutzen, dass mit der erfindungsgemäßen Zusammensetzung trotz Glutenunverträglichkeit oder Zöliakie eine hochwertige Ernährung erfolgen kann und dies in Kombination mit:
- – einer Kohlenhydrat-armen Ernährung für Diabetiker ohne Zuckeraustauschstoffe oder Fruktose-reiche diätetische Lebensmittel,
- – einer ketogenen öl- und fettreichen und proteinbetonten Ernährung bei nachgewiesenem TKTL1-Stoffwechsel,
- – einer energiereichen Ernährung bei längeren Belastungen wie beim Sport
- – einem breiten Spektrum von sekundären Pflanzenstoffen aus natürlichen Quellen.
- - a carbohydrate-poor diet for diabetics without sugar substitutes or fructose-rich dietary foods,
- - a ketogenic oil and fat rich and protein-stressed diet with proven TKTL1 metabolism,
- - a high-energy diet for longer loads as in sports
- - a wide range of phytochemicals from natural sources.
ZITATE ENTHALTEN IN DER BESCHREIBUNG QUOTES INCLUDE IN THE DESCRIPTION
Diese Liste der vom Anmelder aufgeführten Dokumente wurde automatisiert erzeugt und ist ausschließlich zur besseren Information des Lesers aufgenommen. Die Liste ist nicht Bestandteil der deutschen Patent- bzw. Gebrauchsmusteranmeldung. Das DPMA übernimmt keinerlei Haftung für etwaige Fehler oder Auslassungen.This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.
Zitierte PatentliteraturCited patent literature
- EP 1561380 A1 [0007] EP 1561380 A1 [0007]
Claims (16)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202009013228U DE202009013228U1 (en) | 2009-09-30 | 2009-09-30 | Gluten-free foods |
PCT/EP2010/064563 WO2011039308A2 (en) | 2009-09-30 | 2010-09-30 | Gluten-free foodstuff |
EP10773259A EP2482666A2 (en) | 2009-09-30 | 2010-09-30 | Gluten-free foodstuff |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202009013228U DE202009013228U1 (en) | 2009-09-30 | 2009-09-30 | Gluten-free foods |
Publications (1)
Publication Number | Publication Date |
---|---|
DE202009013228U1 true DE202009013228U1 (en) | 2011-02-10 |
Family
ID=43217227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE202009013228U Expired - Lifetime DE202009013228U1 (en) | 2009-09-30 | 2009-09-30 | Gluten-free foods |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2482666A2 (en) |
DE (1) | DE202009013228U1 (en) |
WO (1) | WO2011039308A2 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012097439A1 (en) * | 2011-01-18 | 2012-07-26 | Cleator Iain G M | Healthy organic food |
DE102011054244A1 (en) * | 2011-10-06 | 2013-04-11 | Lutz Müller | Grain flour mixture for baked goods, such as bread, pizza or pretzels, is made of different biological source, seed oil residue or crop oil residue, where seed oil residue or crop oil residue is provided from extraction of edible oils |
FR2981543A1 (en) * | 2011-10-24 | 2013-04-26 | Moulin De Charbonniere | Mixture, useful for manufacturing buckwheat wafers, comprises buckwheat flour, oats cream and extruded linseed meal |
DE102012008271A1 (en) * | 2012-04-23 | 2013-10-24 | Human Nutrition Gmbh | Biscuit, in which fat is substituted by bulking agents, flour is substituted by protein, and sugar is substituted by bulking agents and sweeteners, useful for reducing weight |
EP2844266A2 (en) * | 2012-04-30 | 2015-03-11 | Sonomaceuticals, LLC | Therapeutic use of chardonnay seed products |
EP3020285A1 (en) * | 2014-11-11 | 2016-05-18 | Ernst Rainer Weissenbacher | Composition comprising sourproduct, cereal flour and hops |
WO2017082849A1 (en) * | 2015-11-09 | 2017-05-18 | Vartanian Oleksii | Macaroni comprising vegetable additives |
RU2713687C1 (en) * | 2019-06-27 | 2020-02-06 | федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный аграрный университет" (ФГБОУ ВО Волгоградский ГАУ) | Gluten-free cake composition |
US10744177B2 (en) | 2014-04-21 | 2020-08-18 | Sonomaceuticals, Llc | Therapeutic use of grape seed products |
WO2021144282A1 (en) * | 2020-01-14 | 2021-07-22 | Steinerfood Gmbh | Low-carbohydrate white flour substitute |
AT17323U2 (en) * | 2020-06-26 | 2021-12-15 | Kaufmann Viktor | Noodles with partially de-oiled pumpkin seeds, low in carbohydrates and high in protein |
EP3928635A1 (en) * | 2020-06-26 | 2021-12-29 | MVK Beteiligungs GmbH | Device and composition for producing dough |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010017171A1 (en) * | 2010-05-31 | 2011-12-01 | Ernst Böcker Gmbh & Co. Kg | Rye flour imitation |
IT1401776B1 (en) * | 2010-08-05 | 2013-08-02 | Mr Bio Food S R L | FOOD PRODUCT INCLUDING A BASIC INGREDIENT INCLUDING CEREALS SEEDS |
ITMI20111808A1 (en) * | 2011-10-05 | 2013-04-06 | Ati S R L | FOOD COMPOSITION WITHOUT GLUTEN AND FOOD PRODUCTS WITH IT PREPARED |
CN103404573B (en) * | 2013-08-27 | 2015-09-09 | 西北农林科技大学 | A kind of preparation method of grape pip health cake |
CN103404558B (en) * | 2013-08-27 | 2015-06-24 | 西北农林科技大学 | Grape seed health care cake manufacturing method |
CN104256631B (en) * | 2014-07-10 | 2016-03-16 | 金华明正科技有限公司 | A kind of Smallantus sonchifolium coordinating intestines and stomach flour and preparation method thereof |
EP3484308A1 (en) * | 2016-07-18 | 2019-05-22 | Charrak, Samir | Use of low-gluten flour compositions for producing foodstuffs porridge |
DE102019132894A1 (en) * | 2019-12-03 | 2021-06-10 | Ernst Böcker Gmbh & Co. Kg | BAKING MIX FOR THE PRODUCTION OF GLUTEN-FREE AND HIGH PROTEIN BREADS AND ROLLS |
DE202020101153U1 (en) | 2020-03-02 | 2020-06-30 | Doris Maiwald | Pasta made from a dough based on germinated grain |
CN111557328A (en) * | 2020-05-20 | 2020-08-21 | 南昌大学 | Butter crisp biscuit and preparation method thereof |
Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT26203B (en) * | 1905-12-10 | 1906-10-25 | Robert Goldschmidt | Hatching device. |
DE3535412C2 (en) * | 1985-10-04 | 1989-06-22 | Friedrich 6728 Germersheim De Schmidt | |
DE4001905A1 (en) * | 1990-01-24 | 1991-07-25 | Wilhelm Menge | Mfr. of bakery prods. - from mixt. of cereal materials and pressed oil seeds |
US5234706A (en) * | 1986-01-31 | 1993-08-10 | Slimak K M | Processes for products from potatoes and other roots, seeds, and fruit |
DE69002492T2 (en) * | 1989-03-16 | 1993-12-02 | Procter & Gamble | Cookies containing psyllium with a high fiber content. |
DE19716001A1 (en) * | 1997-04-17 | 1998-10-22 | Juchem Gmbh | Instant muesli contains cereal, flavourings, and dried fruit, milk, yoghurt and/or fruit in plastic coated paper container |
DE10015006A1 (en) * | 1999-08-05 | 2001-09-27 | Vitis Oelmuehlen Kg | Food and food supplements containing cold-pressed grape seed oil and / or stone meal |
DE10038344A1 (en) * | 2000-08-05 | 2002-02-14 | Anne Lehrnickel | Soya product, e.g. muesli (bar), contains soya grits, glucose syrup, brown sugar, linseed, thick agave juice, crisp rice, apricots, oat and rye flakes, Asiatic edible fungi, glycerol, vegetable fat, lecithin, beta-carotene and vitamin E |
DE10303900A1 (en) * | 2003-01-31 | 2004-08-12 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Synergistic cholesterol lowering composition, useful as medicament or food or feed additive, comprising dietary fiber component and ahypocholesterolemic agent, e.g. statin |
WO2005006886A1 (en) * | 2003-07-11 | 2005-01-27 | University Of Florida Research Foundation, Inc. | Chicken-based tortillas |
US20050158438A1 (en) * | 2004-01-16 | 2005-07-21 | Mcmahon David Ii | Recipe for a bread substitute coating for food products |
EP1561380A1 (en) | 2004-02-09 | 2005-08-10 | Shin-Etsu Chemical Co., Ltd. | Gluten-free dough composition |
DE202006006705U1 (en) * | 2005-07-08 | 2006-07-27 | Herrmann Gmbh | Cook-finished paste dough ware for producing taste forming additives, comprises hard wheat semolina, water, additives and kneaded, refined, and dried eggs |
DE60210931T2 (en) * | 2001-02-23 | 2007-01-18 | Aarhuskarlshamn Denmark A/S | METHOD FOR THE TREATMENT OF SOLVENT EXTRACTED PLANT SMALL PARTS WITH A FAT |
DE202006018834U1 (en) * | 2006-12-07 | 2007-02-22 | Coy, Johannes F., Dr. | Composition with a milled grain product, useful for therapeutic or preventive treatment of diseases e.g. cancer, comprises carbohydrate portion and fats e.g. omega-3-fatty acid and proteins |
DE602004004273T2 (en) * | 2003-07-22 | 2007-11-15 | Health & Performance Food International B.V. | PROCESSING OF TEFF FLOUR |
US20070275121A1 (en) * | 2006-05-29 | 2007-11-29 | Jytte Malby | Dry Mixtures for Making Dough for Bread and Methods for Production Thereof |
US20080085343A1 (en) * | 2006-09-14 | 2008-04-10 | Petty Holly T | Novel Low Allergenic Food Bar |
EP1913818A1 (en) * | 2006-10-17 | 2008-04-23 | Uotilan Leipomo Oy | Method of preparing dough containing oat partially in the form of oat flour and partially in the form of oat kernels |
US20090181147A1 (en) * | 2008-01-10 | 2009-07-16 | Azna Gluten Free, Inc. | Compositions and recipes for gluten-free baked products |
EP2001310B1 (en) * | 2006-04-05 | 2010-03-24 | Giuliani S.P.A. | Supplement mixture for dietetic food destined for celiacs |
DE102008056312A1 (en) * | 2008-11-07 | 2010-05-12 | Biogenerics Pharma Gmbh | Use of micro-tablets as food and feed additive |
-
2009
- 2009-09-30 DE DE202009013228U patent/DE202009013228U1/en not_active Expired - Lifetime
-
2010
- 2010-09-30 EP EP10773259A patent/EP2482666A2/en not_active Withdrawn
- 2010-09-30 WO PCT/EP2010/064563 patent/WO2011039308A2/en active Application Filing
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT26203B (en) * | 1905-12-10 | 1906-10-25 | Robert Goldschmidt | Hatching device. |
DE3535412C2 (en) * | 1985-10-04 | 1989-06-22 | Friedrich 6728 Germersheim De Schmidt | |
US5234706A (en) * | 1986-01-31 | 1993-08-10 | Slimak K M | Processes for products from potatoes and other roots, seeds, and fruit |
DE69002492T2 (en) * | 1989-03-16 | 1993-12-02 | Procter & Gamble | Cookies containing psyllium with a high fiber content. |
DE4001905A1 (en) * | 1990-01-24 | 1991-07-25 | Wilhelm Menge | Mfr. of bakery prods. - from mixt. of cereal materials and pressed oil seeds |
DE19716001A1 (en) * | 1997-04-17 | 1998-10-22 | Juchem Gmbh | Instant muesli contains cereal, flavourings, and dried fruit, milk, yoghurt and/or fruit in plastic coated paper container |
DE10015006A1 (en) * | 1999-08-05 | 2001-09-27 | Vitis Oelmuehlen Kg | Food and food supplements containing cold-pressed grape seed oil and / or stone meal |
DE10038344A1 (en) * | 2000-08-05 | 2002-02-14 | Anne Lehrnickel | Soya product, e.g. muesli (bar), contains soya grits, glucose syrup, brown sugar, linseed, thick agave juice, crisp rice, apricots, oat and rye flakes, Asiatic edible fungi, glycerol, vegetable fat, lecithin, beta-carotene and vitamin E |
DE60210931T2 (en) * | 2001-02-23 | 2007-01-18 | Aarhuskarlshamn Denmark A/S | METHOD FOR THE TREATMENT OF SOLVENT EXTRACTED PLANT SMALL PARTS WITH A FAT |
DE10303900A1 (en) * | 2003-01-31 | 2004-08-12 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Synergistic cholesterol lowering composition, useful as medicament or food or feed additive, comprising dietary fiber component and ahypocholesterolemic agent, e.g. statin |
WO2005006886A1 (en) * | 2003-07-11 | 2005-01-27 | University Of Florida Research Foundation, Inc. | Chicken-based tortillas |
DE602004004273T2 (en) * | 2003-07-22 | 2007-11-15 | Health & Performance Food International B.V. | PROCESSING OF TEFF FLOUR |
US20050158438A1 (en) * | 2004-01-16 | 2005-07-21 | Mcmahon David Ii | Recipe for a bread substitute coating for food products |
EP1561380A1 (en) | 2004-02-09 | 2005-08-10 | Shin-Etsu Chemical Co., Ltd. | Gluten-free dough composition |
DE202006006705U1 (en) * | 2005-07-08 | 2006-07-27 | Herrmann Gmbh | Cook-finished paste dough ware for producing taste forming additives, comprises hard wheat semolina, water, additives and kneaded, refined, and dried eggs |
EP2001310B1 (en) * | 2006-04-05 | 2010-03-24 | Giuliani S.P.A. | Supplement mixture for dietetic food destined for celiacs |
US20070275121A1 (en) * | 2006-05-29 | 2007-11-29 | Jytte Malby | Dry Mixtures for Making Dough for Bread and Methods for Production Thereof |
US20080085343A1 (en) * | 2006-09-14 | 2008-04-10 | Petty Holly T | Novel Low Allergenic Food Bar |
EP1913818A1 (en) * | 2006-10-17 | 2008-04-23 | Uotilan Leipomo Oy | Method of preparing dough containing oat partially in the form of oat flour and partially in the form of oat kernels |
DE202006018834U1 (en) * | 2006-12-07 | 2007-02-22 | Coy, Johannes F., Dr. | Composition with a milled grain product, useful for therapeutic or preventive treatment of diseases e.g. cancer, comprises carbohydrate portion and fats e.g. omega-3-fatty acid and proteins |
US20090181147A1 (en) * | 2008-01-10 | 2009-07-16 | Azna Gluten Free, Inc. | Compositions and recipes for gluten-free baked products |
DE102008056312A1 (en) * | 2008-11-07 | 2010-05-12 | Biogenerics Pharma Gmbh | Use of micro-tablets as food and feed additive |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012097439A1 (en) * | 2011-01-18 | 2012-07-26 | Cleator Iain G M | Healthy organic food |
DE102011054244A1 (en) * | 2011-10-06 | 2013-04-11 | Lutz Müller | Grain flour mixture for baked goods, such as bread, pizza or pretzels, is made of different biological source, seed oil residue or crop oil residue, where seed oil residue or crop oil residue is provided from extraction of edible oils |
FR2981543A1 (en) * | 2011-10-24 | 2013-04-26 | Moulin De Charbonniere | Mixture, useful for manufacturing buckwheat wafers, comprises buckwheat flour, oats cream and extruded linseed meal |
DE102012008271A1 (en) * | 2012-04-23 | 2013-10-24 | Human Nutrition Gmbh | Biscuit, in which fat is substituted by bulking agents, flour is substituted by protein, and sugar is substituted by bulking agents and sweeteners, useful for reducing weight |
US11723943B2 (en) | 2012-04-30 | 2023-08-15 | Sonomaceuticals, Llc | Therapeutic use of chardonnay seed products |
EP2844266A2 (en) * | 2012-04-30 | 2015-03-11 | Sonomaceuticals, LLC | Therapeutic use of chardonnay seed products |
US10105409B2 (en) | 2012-04-30 | 2018-10-23 | Sonomaceuticals, Llc | Therapeutic use of chardonnay seed products |
US10772924B2 (en) | 2012-04-30 | 2020-09-15 | Sonomaceuticals, Llc | Therapeutic use of chardonnay seed products |
EP2844266B1 (en) * | 2012-04-30 | 2024-09-11 | Sonomaceuticals, LLC | Therapeutic use of chardonnay seed products |
US10744177B2 (en) | 2014-04-21 | 2020-08-18 | Sonomaceuticals, Llc | Therapeutic use of grape seed products |
EP3020285A1 (en) * | 2014-11-11 | 2016-05-18 | Ernst Rainer Weissenbacher | Composition comprising sourproduct, cereal flour and hops |
WO2017082849A1 (en) * | 2015-11-09 | 2017-05-18 | Vartanian Oleksii | Macaroni comprising vegetable additives |
RU2713687C1 (en) * | 2019-06-27 | 2020-02-06 | федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный аграрный университет" (ФГБОУ ВО Волгоградский ГАУ) | Gluten-free cake composition |
WO2021144282A1 (en) * | 2020-01-14 | 2021-07-22 | Steinerfood Gmbh | Low-carbohydrate white flour substitute |
EP3928635A1 (en) * | 2020-06-26 | 2021-12-29 | MVK Beteiligungs GmbH | Device and composition for producing dough |
AT17323U3 (en) * | 2020-06-26 | 2022-02-15 | Kaufmann Viktor | Noodles with partially de-oiled pumpkin seeds, low in carbohydrates and high in protein |
AT17399U1 (en) * | 2020-06-26 | 2022-03-15 | Kaufmann Viktor | Method of making pasta |
AT17323U2 (en) * | 2020-06-26 | 2021-12-15 | Kaufmann Viktor | Noodles with partially de-oiled pumpkin seeds, low in carbohydrates and high in protein |
Also Published As
Publication number | Publication date |
---|---|
WO2011039308A2 (en) | 2011-04-07 |
EP2482666A2 (en) | 2012-08-08 |
WO2011039308A3 (en) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE202009013228U1 (en) | Gluten-free foods | |
EP3160236B1 (en) | Composition for low-gluten and low-carbohydrate baked and pastry goods | |
Ibrahim et al. | Bread towards functional food: an overview | |
Alam et al. | Development of fiber enriched herbal biscuits: a preliminary study on sensory evaluation and chemical composition | |
Akoja et al. | Physicochemical, functional, pasting and sensory properties of wheat flour biscuit incorporated with Okra powder | |
AT15542U1 (en) | Gluten-free baked goods | |
EP4090171A1 (en) | Low-carbohydrate white flour substitute | |
KR20160071747A (en) | Manufacturing method of snack | |
Omran et al. | Quality characteristics of biscuit prepared from wheat and flaxseed flour | |
Mishra | Utilization of waste defatted rice bran in formulation of functional cookies and its effect on physiochemical characteristic of cookies | |
KR20150094507A (en) | functional cereal containing sweet potato chip, broccoli granule and dietary fiber for constipation improving and manufacturing method thereof | |
KR101558212B1 (en) | Method for producing cookie using Opunita humifusa powder and cookie produced by same method | |
WO2018015322A1 (en) | Use of low-gluten flour compositions for producing foodstuffs porridge | |
KR101822515B1 (en) | Method of aronia cookies | |
Sturza et al. | Use of sea buckthorn fruits in the pastry manufacturing | |
EP1448064A1 (en) | Dosage form of aleuron | |
AT9618U1 (en) | FLOUR MIXTURE AND BREAD MADE FROM THIS FLUID MIXTURE | |
WO2018202787A1 (en) | Foodstuff to produce positive health effects | |
EP4282277A1 (en) | Puffed food composition containing beans and/or millet, and method for producing same | |
KR101578666B1 (en) | Manufacturing method of Korea hot pepper paste pencake using sap of Acer mono | |
Duruanyanwu et al. | Proximate Composition and Microbiological Evaluation of Cookies Produced from Whole Wheat Flour, Unripe Plantain Flour (R. markham) and Moringa oleifera Leaf Powder | |
EP3491925B1 (en) | Long life pastry for specific nutritional purposes and method of its production | |
DE102017118589B4 (en) | Bread dough for whole wheat mixed bread and whole wheat mixed bread | |
WO2012075999A1 (en) | Food extrudate | |
Aziz et al. | Preparation of fortified bread by incorporating blends of Helianthus annuus and Myristica fragrans flours: Assessment of functional, physicochemical, and organoleptic properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R163 | Identified publications notified | ||
R207 | Utility model specification |
Effective date: 20110317 |
|
R150 | Utility model maintained after payment of first maintenance fee after three years |
Effective date: 20121025 |
|
R157 | Lapse of ip right after 6 years |